Rory Collins created and led large studies that transformed statins from esoteric drugs for familial hypercholesterolaemia into safe, widely-used generics that annually prevent millions of heart attacks and ischaemic strokes. His large placebo-controlled trials and worldwide Cholesterol Treatment Trialists’ meta-analyses confirmed heart attack reduction, discovered stroke reduction, and demonstrated safety and efficacy in many different types of patient.
Professional position
- Nuffield Professor of Population Health, Nuffield Department of Population Health, University of Oxford
Subject groups
-
Health and Human Sciences
Clinical epidemiology, Medical statistics and demography, Medicine, clinical studies
